Latest On CohBar, Inc (CWBR):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-23 11:22 EST | News | CohBar surges ~130% on proposed merger with cancer vaccine developer Morphogenesis | N/A |  |
| 2022-11-12 03:41 EST | News | CohBar, Inc. (CWBR) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-09 04:40 EST | News | CohBar GAAP EPS of -$0.82 | N/A | |
| 2022-09-22 16:17 EST | News | CohBar stock gains on 1-for-30 reverse stock split | N/A | |
| 2022-08-16 06:37 EST | News | CohBar GAAP EPS of -$0.03 beats by $0.01 | N/A | |
| 2022-08-16 06:37 EST | News | CohBar, Inc. (CWBR) CEO Joe Sarret on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-17 05:32 EST | News | CohBar GAAP EPS of -$0.04 in-line | N/A | |
| 2022-05-17 05:31 EST | News | CohBar Inc. (CWBR) CEO Joe Sarret on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-14 14:32 EST | News | CohBar Q1 2022 Earnings Preview | N/A | |
| 2022-05-12 16:11 EST | News | CohBar gets 180-day extension to regain compliance with Nasdaq listing rule | N/A | |
| 2022-03-30 00:20 EST | News | CohBar GAAP EPS of -$0.04 beats by $0.01 | N/A | |
| 2022-03-30 00:20 EST | News | CohBar, Inc. (CWBR) CEO Joe Sarret on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2021-12-17 21:16 EST | News | CohBar announces changes to board of directors, resignation of CSO | N/A | |
| 2021-11-15 23:36 EST | News | CohBar EPS beats by $0.03 | N/A | |
| 2021-11-15 23:36 EST | News | CohBar, Inc. (CWBR) CEO Joe Sarret on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-10-28 19:44 EST | News | CohBar slumps ~32% on pricing of ~$15M stock, warrants offering | N/A | |
| 2021-10-27 16:58 EST | News | CohBar slumps in trade on launching stock and warrants offering | N/A | |
| 2021-10-12 23:29 EST | News | Warning: CWBR is at high risk of performing badly | N/A | |
| 2021-10-07 08:29 EST | News | CWBR is at high risk of performing badly | N/A | |
| 2021-09-27 16:04 EST | News | Warning: CWBR has been downgraded to Very Bearish | N/A | |
| 2021-09-21 16:05 EST | News | Warning: CWBR has been downgraded to Very Bearish. | N/A | |
| 2021-08-10 23:25 EST | News | CohBar shares rise 10% on topline results from early-stage NASH study | N/A | |
| 2021-08-10 23:24 EST | News | CohBar's (CWBR) CEO Joe Sarret on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-21 03:40 EST | News | CohBar shares drop on early-stage CB4211 data timeline update | N/A | |
| 2021-04-27 15:22 EST | News | CohBar appoints Joseph Sarret as CEO and Director | N/A | |
| 2021-04-24 08:13 EST | News | CohBar: A Promising Early Pureplay On Mitochondrial-Based Therapeutics | N/A | |
| 2021-03-31 00:00 EST | News | CohBar Q4 EPS misses by $0.03 | N/A | |
| 2021-03-31 00:00 EST | News | CohBar, Inc. (CWBR) CEO Steve Engle on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-31 00:00 EST | News | CohBar, Inc. 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2021-03-17 16:25 EST | Analyst Rating | The Analyst Target Price has decreased from $6.38 to $6.3. | Neutral | |
| 2021-01-11 16:41 EST | News | CohBar collaborates with NIAID for CB5064 analogs in COVID-19-related ARDS | N/A | |
| 2020-12-18 03:29 EST | Analyst Rating | The Analyst Target Price has decreased from $7.5 to $6.38. | Neutral | |
| 2020-12-13 03:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-22 17:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-20 19:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-18 11:50 EST | News | CohBar, Inc. (CWBR) CEO Steve Engle on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-17 11:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-17 06:07 EST | News | CohBar EPS in-line | N/A | |
| 2020-11-17 06:06 EST | News | CohBar, Inc. 2020 Q3 - Results - Earnings Call Presentation | N/A | |
| 2020-11-17 03:42 EST | Earnings Estimate | An EPS average of -$0.06 is estimated for the quarter ending on March 31, 2021. | N/A | |
| 2020-11-07 15:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-30 12:42 EST | Analyst Rating | The Analyst Target Price has decreased from $8 to $7.5. | Neutral | |
| 2020-09-26 12:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-23 00:41 EST | Earnings Estimate | An EPS average of -$0.22 is estimated for the 2021 year. | Sell | |
| 2020-09-23 00:41 EST | Earnings Estimate | An EPS average of -$0.29 is estimated for the 2020 year. | Sell | |
| 2020-09-23 00:41 EST | Earnings Estimate | An EPS average of -$0.05 is estimated for the quarter ending on September 30, 2020. | Buy | |
| 2020-09-23 00:41 EST | Analyst Rating | The Analyst Target Price has increased from $0 to $8. | Buy | |
| 2020-09-17 04:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-04 09:04 EST | Insider Trade | Misha Petkevich has indirectly acquired of 11,000 shares. | Buy | |
| 2020-09-03 09:19 EST | Insider Trade | Misha Petkevich has indirectly acquired of 6,000 shares. | Buy | |
About CohBar, Inc (CWBR):
CohBar, Inc., a clinical stage biotechnology company, engages in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes mellitus, cancer, atherosclerosis, cardiovascular, and neurodegenerative diseases, such as Alzheimer's disease. Its lead MBT candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial-derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of nonalcoholic steatohepatitis (NASH) and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases, CB5064 analogs for COVID-19 associated ARDS, MBT5 analogs for CXCR4-related cancer and orphan diseases, and MBT3 analogs for cancer immunotherapy. The company was founded in 2007 and is headquartered in Menlo Park, California.
General
- Name CohBar, Inc
- Symbol CWBR
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 12
- Fiscal Year EndDecember
- IPO Date2015-01-28
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.cohbar.com
View More
Valuation
- Price/Book (Most Recent Quarter) 5.26
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.08
- Return on Assets -39%
- Return on Equity -102%
- Earnings Per Share -$0.35
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 91.68 million
- EBITDA -14262793
- Analyst Target Price $6.3
- Book Value Per Share $0.33
View More
Share Statistics
- Shares Outstanding 61.12 million
- Shares Float 45.14 million
- % Held by Insiders 2448%
- % Held by Institutions 12.34%
- Shares Short 2.76 million
- Shares Short Prior Month 2.87 million
- Short Ratio 2.89
- Short % of Float 6%
- Short % of Shares Outstanding 5%
View More
Technicals
- Beta 2.72
- 52 Week High $4.25
- 52 Week Low $0.87
- 50 Day Moving Average 1.66
- 200 Day Moving Average 1.29
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
CohBar, Inc (CWBR) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
CohBar, Inc (CWBR) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-16 | $N/A | -$0.06 | -$0.05 | -20% |
| 2020-06-30 | 2020-08-13 | $N/A | -$0.09 | -$0.06 | -50% |
| 2020-03-31 | 2020-05-14 | $N/A | -$0.10 | ||
| 2019-12-31 | 2020-03-12 | $N/A | -$0.09 | ||
| 2019-09-30 | 2019-11-06 | $N/A | -$0.08 | ||
| 2019-06-30 | 2019-08-07 | $N/A | -$0.07 | ||
| 2019-03-31 | 2019-05-07 | $N/A | -$0.07 | ||
| 2018-12-31 | 2018-12-31 | $N/A | -$0.10 | ||
| 2018-09-30 | 2018-09-30 | $N/A | -$0.11 | ||
| 2018-06-30 | 2018-06-30 | $N/A | -$0.08 | ||
| 2018-03-31 | 2018-03-31 | $N/A | -$0.09 | ||
| 2017-12-31 | 2017-12-31 | $N/A | -$0.07 | ||
| 2017-09-30 | 2017-09-30 | $N/A | -$0.07 | ||
| 2017-06-30 | 2017-06-30 | $N/A | -$0.05 | ||
| 2017-03-31 | 2017-03-31 | $N/A | -$0.06 | ||
| 2016-12-31 | 2016-12-31 | $N/A | -$0.05 | ||
| 2016-09-30 | 2016-09-30 | $N/A | -$0.05 | ||
| 2016-06-30 | 2016-06-30 | $N/A | -$0.05 | ||
| 2016-03-31 | 2016-03-31 | $N/A | -$0.04 | ||
| 2015-12-31 | 2015-12-31 | -$0.04 | |||
| 2015-09-30 | 2015-09-30 | $N/A | -$0.03 | ||
| 2015-06-30 | 2015-06-30 | $N/A | -$0.03 | ||
| 2015-03-31 | 2015-03-31 | $N/A | -$0.03 |
CohBar, Inc (CWBR) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | 1.45 million | 1.9 million | 1.94 million |
| Income Before Tax | N/A | N/A | -4.22 million | -3.72 million | -3.35 million |
| Selling General Administrative | N/A | N/A | 1.83 million | 1.67 million | 1.28 million |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Ebit | N/A | N/A | -4 million | -3.57 million | -3.23 million |
| Operating Income | N/A | N/A | -3.28 million | -3.57 million | -3.23 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Total Other Income Expense Net | N/A | N/A | -802400 | -146928 | -121960 |
| Net Income From Continuing Operations | N/A | N/A | -4.22 million | -3.72 million | -3.35 million |
| Net Income Applicable to Common Shares | -3.24 million | -4.1 million | N/A | -3.72 million | -3.35 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | -10344 | 13.42 million | N/A |
| Change to Liabilities | -279365 | 290225 | N/A | 67381 | N/A |
| Total Cash Flow from Investing Activities | -8.64 million | -250255 | N/A | 13.29 million | N/A |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | N/A | 42226 | 278538 | N/A |
| Change to Operating Activities | -79863 | -333811 | N/A | 899740 | N/A |
| Change in Cash | N/A | N/A | -2.4 million | 11.54 million | N/A |
| Total Cash from Operating Activities | -2.64 million | -2.36 million | -2.43 million | -2.03 million | N/A |
| Depreciation | N/A | N/A | 43958 | 40568 | N/A |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | -4201 | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | 862845 | 1.65 million | N/A | 565311 | N/A |
| Capital Expenditures | N/A | N/A | 7183 | 128231 | N/A |
Balance Sheet:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | 5.39 million | 5.4 million | 4.44 million |
| Total Stockholder Equity | N/A | N/A | 5.65 million | 8.14 million | 10.98 million |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A |
| Total Assets | N/A | N/A | 11.04 million | 13.53 million | 15.42 million |
| Common Stock | 57963 | 45645 | N/A | 43069 | 42861 |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -64.55 million | -61.31 million | -57.21 million | -52.99 million | -49.28 million |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A |
| Other Assets | 67403 | 67403 | N/A | 64242 | 60041 |
| Cash | N/A | N/A | 10.17 million | 12.56 million | 1.03 million |
| Total Current Liabilities | 2.34 million | N/A | 2.03 million | 2.04 million | 1.2 million |
| Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Property, Plant & Equipment | 432403 | 448086 | N/A | 523677 | 435745 |
| Total Current Assets | 23.98 million | N/A | 10.47 million | 12.93 million | 14.9 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 19.02 million | 7.72 million | N/A | 8.12 million | 10.96 million |
| Short Term Investments | N/A | N/A | N/A | N/A | 13.39 million |
| Long Term Debt | N/A | N/A | 3.37 million | 3.36 million | 3.25 million |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 472984 | N/A | 462124 | 444776 | 377395 |
CohBar, Inc (CWBR) Chart:
CohBar, Inc (CWBR) News:
Below you will find a list of latest news for CohBar, Inc (CWBR) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
CohBar, Inc (CWBR) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest CWBR Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 1:39 PM EST | 100 | $0.2207 |
| Jun 13, 2022 1:47 PM EST | 100 | $0.2012 |
| Jun 13, 2022 7:58 PM EST | 100 | $0.2056 |
CohBar, Inc (CWBR) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-08-31 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1522602/000000000020008182/0000000000-20-008182-index.htm |
| 2020-09-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1522602/000091957420005725/0000919574-20-005725-index.htm |
| 2019-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1522602/000121390019014802/0001213900-19-014802-index.htm |
| 2019-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1522602/000121390019015060/0001213900-19-015060-index.htm |
| 2019-10-22 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390019020813/0001213900-19-020813-index.htm |
| 2019-10-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390019020814/0001213900-19-020814-index.htm |
| 2019-10-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1522602/000121390019020867/0001213900-19-020867-index.htm |
| 2019-10-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390019021510/0001213900-19-021510-index.htm |
| 2019-10-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390019021625/0001213900-19-021625-index.htm |
| 2019-11-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390019021801/0001213900-19-021801-index.htm |
| 2019-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390019022202/0001213900-19-022202-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1522602/000121390019022204/0001213900-19-022204-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1522602/000121390019022339/0001213900-19-022339-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390019022911/0001213900-19-022911-index.htm |
| 2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390019023886/0001213900-19-023886-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390019024049/0001213900-19-024049-index.htm |
| 2019-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390019026443/0001213900-19-026443-index.htm |
| 2020-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020001184/0001213900-20-001184-index.htm |
| 2020-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020001186/0001213900-20-001186-index.htm |
| 2020-01-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020001543/0001213900-20-001543-index.htm |
| 2020-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020002005/0001213900-20-002005-index.htm |
| 2020-01-30 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020002139/0001213900-20-002139-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020002565/0001213900-20-002565-index.htm |
| 2020-02-05 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020002675/0001213900-20-002675-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020004621/0001213900-20-004621-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020004622/0001213900-20-004622-index.htm |
| 2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1522602/000121390020006115/0001213900-20-006115-index.htm |
| 2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1522602/000121390020006119/0001213900-20-006119-index.htm |
| 2020-03-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1522602/000121390020007839/0001213900-20-007839-index.htm |
| 2020-04-14 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1522602/000121390020009118/0001213900-20-009118-index.htm |
| 2020-04-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020009933/0001213900-20-009933-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1522602/000121390020010351/0001213900-20-010351-index.htm |
| 2020-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1522602/000121390020011914/0001213900-20-011914-index.htm |
| 2020-05-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1522602/000121390020012261/0001213900-20-012261-index.htm |
| 2020-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1522602/000121390020012266/0001213900-20-012266-index.htm |
| 2020-05-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020012811/0001213900-20-012811-index.htm |
| 2020-05-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1522602/000121390020013532/0001213900-20-013532-index.htm |
| 2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1522602/000121390020013534/0001213900-20-013534-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020015186/0001213900-20-015186-index.htm |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1522602/000121390020015254/0001213900-20-015254-index.htm |
| 2020-06-23 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1522602/000121390020015572/0001213900-20-015572-index.htm |
| 2020-07-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1522602/000121390020017076/0001213900-20-017076-index.htm |
| 2020-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020021161/0001213900-20-021161-index.htm |
| 2020-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1522602/000121390020021866/0001213900-20-021866-index.htm |
| 2020-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1522602/000121390020021868/0001213900-20-021868-index.htm |
| 2020-08-24 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1522602/000121390020023466/0001213900-20-023466-index.htm |
| 2020-08-25 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1522602/000121390020023682/0001213900-20-023682-index.htm |
| 2020-08-26 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1522602/000121390020023831/0001213900-20-023831-index.htm |
| 2020-08-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1522602/000121390020023834/0001213900-20-023834-index.htm |
| 2020-08-31 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1522602/000121390020024599/0001213900-20-024599-index.htm |
| 2020-09-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020024779/0001213900-20-024779-index.htm |
| 2020-09-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020024781/0001213900-20-024781-index.htm |
| 2020-09-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020024782/0001213900-20-024782-index.htm |
| 2020-09-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020024785/0001213900-20-024785-index.htm |
| 2020-09-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020024786/0001213900-20-024786-index.htm |
| 2020-09-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020024787/0001213900-20-024787-index.htm |
| 2020-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020025152/0001213900-20-025152-index.htm |
| 2020-09-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1522602/000121390020025331/0001213900-20-025331-index.htm |
| 2020-09-03 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1522602/999999999520002374/9999999995-20-002374-index.htm |
CohBar, Inc (CWBR) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of CohBar, Inc (CWBR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 2448%Institutional Ownership: 1234%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-08-06 | Kenneth C Cundy | Chief Scientific Officer | Sell | 10,000.00 | 1.90 | 19,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1522602/000121390020021161/0001213900-20-021161-index.htm |
| 2020-08-28 | DAVID GREENWOOD | Director | Buy | 20,000.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1522602/000121390020024782/0001213900-20-024782-index.htm | ||
| 2020-08-06 | Kenneth C Cundy | Chief Scientific Officer | Buy | 10,000.00 | 0.73 | 7,300.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1522602/000121390020021161/0001213900-20-021161-index.htm |
| 2020-08-28 | Misha Petkevich | Director | Buy | 204,918.00 | 223,609.00 | https://www.sec.gov/Archives/edgar/data/1522602/000121390020024785/0001213900-20-024785-index.htm | ||
| 2020-09-02 | Misha Petkevich | Director | Buy | 6,000.00 | 1.00 | 6,000.00 | 229,609.00 | https://www.sec.gov/Archives/edgar/data/1522602/000121390020025152/0001213900-20-025152-index.htm |
| 2020-09-03 | Misha Petkevich | Director | Buy | 11,000.00 | 1.02 | 11,220.00 | 240,609.00 | https://www.sec.gov/Archives/edgar/data/1522602/000121390020025331/0001213900-20-025331-index.htm |
| 2020-08-28 | Jon Leland Stern | Director | Buy | 8,169.00 | 574,151.00 | https://www.sec.gov/Archives/edgar/data/1522602/000121390020024787/0001213900-20-024787-index.htm | ||
| 2020-08-28 | ALBION FITZGERALD | Director | Buy | 8,196.00 | 937,863.00 | https://www.sec.gov/Archives/edgar/data/1522602/000121390020024781/0001213900-20-024781-index.htm |